Comparison of two algorithms to support medication surveillance for drug-drug interactions between QTc-prolonging drugs

被引:0
|
作者
Berger, Florine A. [1 ]
van der Sijs, Heleen [1 ]
van Gelder, T. [1 ,2 ]
Kuijper, Aaf F.M. [3 ]
van den Bemt, Patricia M.L.A. [1 ,4 ]
Becker, Matthijs L. [5 ]
机构
[1] Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands
[2] Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands
[3] Department of Cardiology, Spaarne Gasthuis, Hoofddorp, Netherlands
[4] Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, Netherlands
[5] Pharmacy Foundation of Haarlem Hospitals, Haarlem, Netherlands
关键词
30;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Drug-drug interactions between immunosuppressants and antidiabetic drugs in the treatment of post-transplant diabetes mellitus
    Vanhove, Thomas
    Remijsen, Quinten
    Kuypers, Dirk
    Gillard, Pieter
    TRANSPLANTATION REVIEWS, 2017, 31 (02) : 69 - 77
  • [42] Drug-drug interactions between propofol and ART drugs: Inhibiting neuronal activity by affecting glucose metabolism
    Li, Sijun
    Zheng, Yanqing
    Long, Qian
    Nong, Jianhong
    Shao, Honghua
    Liang, Gang
    Wu, Fengyao
    CNS NEUROSCIENCE & THERAPEUTICS, 2024, 30 (03)
  • [43] Assessment of drug-drug interactions between moxonidine and antiepileptic drugs in the maximal electroshock seizure test in mice
    Lukawski, Krzysztof
    Czuczwar, Stanislaw Jerzy
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2022, 130 (01) : 28 - 34
  • [44] Potential drug-drug interactions between anti-cancer agents and community pharmacy dispensed drugs
    Voll, Marsha L.
    Yap, Kim D.
    Terpstra, Wim E.
    Crul, Mirjam
    PHARMACY WORLD & SCIENCE, 2010, 32 (05): : 575 - 580
  • [45] Use of a physiologically based pharmacokinetic model to simulate drug-drug interactions between antineoplastic and antiretroviral drugs
    Molto, Jose
    Rajoli, Rajith
    Back, David
    Valle, Marta
    Miranda, Cristina
    Owen, Andrew
    Clotet, Bonaventura
    Siccardi, Marco
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (03) : 805 - 811
  • [46] Letter to the Editor: Possible Drug-Drug Interactions Between Cannabinoids and Candidate COVID-19 Drugs
    Land, M. Hunter
    MacNair, Laura
    Thomas, Brian F.
    Peters, Erica N.
    Bonn-Miller, Marcel O.
    CANNABIS AND CANNABINOID RESEARCH, 2020, 5 (04) : 340 - 343
  • [47] Clinical Decision Support Drug-Drug Interaction Alert Overrides: A Comparison Between Intensive Care
    Buckley, Mitchell
    Kazem, Nadine
    Wicks, Laura
    Smithburger, Pamela
    Kane-Gill, Sandra
    CRITICAL CARE MEDICINE, 2013, 41 (12)
  • [48] Real-life drug-drug and herb-drug interactions in outpatients taking oral anticancer drugs: comparison with databases
    Prely, H.
    Herledan, C.
    Caffin, A. G.
    Baudouin, A.
    Larbre, V
    Maire, M.
    Schwiertz, V
    Vantard, N.
    Ranchon, F.
    Rioufol, C.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (03) : 707 - 718
  • [49] A 6-year retrospective study of adverse drug reactions due to drug-drug interactions between nervous system drugs
    Shi, Qing-ping
    He, Xian-di
    Yu, Mei-ling
    Zhu, Jin-xiu
    Liu, Yan
    Ding, Feng
    Sang, Rang
    Jiang, Xiao-dong
    Zhang, Shu-qiang
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (05) : 392 - 401
  • [50] ASSAY TO STUDY DRUG-DRUG INTERACTIONS BETWEEN CITALOPRAME AND ADDITIONALLY PRESCRIBED PSYCHOTROPIC DRUGS IN HUMAN LIVER MICROSOMES
    Brandl, R.
    Jahner, T.
    Beck, S.
    Melchner, D.
    Haen, E.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 : 33 - 33